Copyright © 2009 U. R. Goonetilleke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. K.-J. Lee, S.-M. Bae, M.-R. Lee, S.-M. Yeon, Y.-H. Lee, and K.-S. Kim, “Proteomic analysis of growth phase-dependent proteins of Streptococcus pneumoniae,” Proteomics, vol. 6, no. 4, pp. 1274–1282, 2006. View at Publisher · View at Google Scholar · View at PubMed
2. S. B. Gordon, A. L. Walsh, M. Chaponda, et al., “Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal,” Clinical Infectious Diseases, vol. 31, no. 1, pp. 53–57, 2000. View at Publisher · View at Google Scholar · View at PubMed
3. D. M. Cardozo, C. M. C. Nascimento-Carvalho, F. R. Souza, and N. M. S. Silva, “Nasopharyngeal colonization and penicillin resistance among pneumococcal strains: a worldwide 2004 update,” Brazilian Journal of Infectious Diseases, vol. 10, no. 4, pp. 293–303, 2006. View at Publisher · View at Google Scholar
4. A. Roche, P. T. Heath, M. Sharland, et al., “Prevalence of nasopharyngeal carriage of pneumococcus in preschool children attending day care in London,” Archives of Disease in Childhood, vol. 92, no. 12, pp. 1073–1076, 2007. View at Publisher · View at Google Scholar · View at PubMed
5. P. C. Hill, A. Akisanya, K. Sankareh, et al., “Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers,” Clinical Infectious Diseases, vol. 43, no. 6, pp. 673–679, 2006. View at Publisher · View at Google Scholar · View at PubMed
6. S. B. Gordon, M. Chaponda, A. L. Walsh, et al., “Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival,” AIDS, vol. 16, no. 10, pp. 1409–1417, 2002. View at Publisher · View at Google Scholar
7. D. van de Beek, J. de Gans, A. R. Tunkel, and E. F. M. Wijdicks, “Community-acquired bacterial meningitis in adults,” The New England Journal of Medicine, vol. 354, no. 1, pp. 44–53, 2006. View at Publisher · View at Google Scholar · View at PubMed
8. J. N. Weiser, D. Bae, H. Epino, et al., “Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae,” Infection and Immunity, vol. 69, no. 9, pp. 5430–5439, 2001. View at Publisher · View at Google Scholar
9. D. M. Moody, “The blood-brain barrier and blood-cerebral spinal fluid barrier,” Seminars in Cardiothoracic and Vascular Anesthesia, vol. 10, no. 2, pp. 128–131, 2006. View at Publisher · View at Google Scholar · View at PubMed
10. D. Bermpohl, A. Halle, D. Freyer, et al., “Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways,” The Journal of Clinical Investigation, vol. 115, no. 6, pp. 1607–1615, 2005. View at Publisher · View at Google Scholar · View at PubMed
11. J. R. Weber and E. I. Tuomanen, “Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity,” Journal of Neuroimmunology, vol. 184, no. 1-2, pp. 45–52, 2007. View at Publisher · View at Google Scholar · View at PubMed
12. F. W. van Ginkel, J. R. McGhee, J. M. Watt, A. Campos-Torres, L. A. Parish, and D. E. Briles, “Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, pp. 14363–14367, 2003. View at Publisher · View at Google Scholar · View at PubMed
13. A. Marra and D. Brigham, “Streptococcus pneumoniae causes experimental meningitis following intranasal and otitis media infections via a nonhematogenous route,” Infection and Immunity, vol. 69, no. 12, pp. 7318–7325, 2001. View at Publisher · View at Google Scholar · View at PubMed
14. H. M. Marriott and D. H. Dockrell, “Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis,” The International Journal of Biochemistry & Cell Biology, vol. 38, no. 11, pp. 1848–1854, 2006. View at Publisher · View at Google Scholar · View at PubMed
15. J. Zweigner, S. Jackowski, S. H. Smith, M. van der Merwe, J. R. Weber, and E. I. Tuomanen, “Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain,” Journal of Experimental Medicine, vol. 200, no. 1, pp. 99–106, 2004. View at Publisher · View at Google Scholar · View at PubMed
16. U. Koedel, W. M. Scheld, and H.-W. Pfister, “Pathogenesis and pathophysiology of pneumococcal meningitis,” The Lancet Infectious Diseases, vol. 2, no. 12, pp. 721–736, 2002. View at Publisher · View at Google Scholar
17. R. Nau and W. Brück, “Neuronal injury in bacterial meningitis: mechanisms and implications for therapy,” Trends in Neurosciences, vol. 25, no. 1, pp. 38–45, 2002. View at Publisher · View at Google Scholar
18. A. Spreer, J. Gerber, D. Baake, M. Hanssen, G. Huether, and R. Nau, “Antiinflammatory but no neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacterial meningitis,” Journal of Neuroscience Research, vol. 84, no. 7, pp. 1575–1579, 2006. View at Publisher · View at Google Scholar · View at PubMed
19. J. S. Braun, R. Novak, K.-H. Herzog, S. M. Bodner, J. L. Cleveland, and E. I. Tuomanen, “Neuroprotection by a caspase inhibitor in acute bacterial meningitis,” Nature Medicine, vol. 5, no. 3, pp. 298–302, 1999. View at Publisher · View at Google Scholar · View at PubMed
20. G. Zysk, W. Brück, J. Gerber, Y. Brück, H. W. Prange, and R. Nau, “Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis,” Journal of Neuropathology and Experimental Neurology, vol. 55, no. 6, pp. 722–728, 1996. View at Publisher · View at Google Scholar
21. L. Mitchell, S. H. Smith, J. S. Braun, K.-H. Herzog, J. R. Weber, and E. I. Tuomanen, “Dual phases of apoptosis in pneumococcal meningitis,” The Journal of Infectious Diseases, vol. 190, no. 11, pp. 2039–2046, 2004. View at Publisher · View at Google Scholar · View at PubMed
22. Y.-D. Bifrare, J. Kummer, P. Joss, M. G. Täuber, and S. L. Leib, “Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis,” The Journal of Infectious Diseases, vol. 191, no. 1, pp. 40–45, 2005. View at Publisher · View at Google Scholar · View at PubMed
23. Y.-D. Bifrare, C. Gianinazzi, H. Imboden, S. L. Leib, and M. G. Täuber, “Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats,” Hippocampus, vol. 13, no. 4, pp. 481–488, 2003. View at Publisher · View at Google Scholar · View at PubMed
24. D. Grandgirard, O. Steiner, M. G. Täuber, and S. L. Leib, “An infant mouse model of brain damage in pneumococcal meningitis,” Acta Neuropathologica, vol. 114, no. 6, pp. 609–617, 2007. View at Publisher · View at Google Scholar · View at PubMed
25. D. van de Beek, J. de Gans, L. Spanjaard, M. Weisfelt, J. B. Reitsma, and M. Vermeulen, “Clinical features and prognostic factors in adults with bacterial meningitis,” The New England Journal of Medicine, vol. 351, no. 18, pp. 1849–1859, 2004. View at Publisher · View at Google Scholar · View at PubMed
26. J. S. Braun, O. Hoffmann, M. Schickhaus, et al., “Pneumolysin causes neuronal cell death through mitochondrial damage,” Infection and Immunity, vol. 75, no. 9, pp. 4245–4254, 2007. View at Publisher · View at Google Scholar · View at PubMed
27. D. Kögel, B. Svensson, E. Copanaki, et al., “Induction of transcription factor CEBP homology protein mediates hypoglycaemia-induced necrotic cell death in human neuroblastoma cells,” Journal of Neurochemistry, vol. 99, no. 3, pp. 952–964, 2006. View at Publisher · View at Google Scholar · View at PubMed
28. J. Niquet, D.-W. Seo, and C. G. Wasterlain, “Mitochondrial pathways of neuronal necrosis,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1347–1351, 2006. View at Publisher · View at Google Scholar · View at PubMed
29. M. G. Tauber, H. Khayam-Bashi, and M. A. Sande, “Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis,” The Journal of Infectious Diseases, vol. 151, no. 3, pp. 528–534, 1985.
30. J. de Gans and D. van de Beek, “Dexamethasone in adults with bacterial meningitis,” The New England Journal of Medicine, vol. 347, no. 20, pp. 1549–1556, 2002. View at Publisher · View at Google Scholar · View at PubMed
31. E. M. Molyneux, A. L. Walsh, H. Forsyth, et al., “Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial,” The Lancet, vol. 360, no. 9328, pp. 211–218, 2002. View at Publisher · View at Google Scholar
32. M. Scarborough, S. B. Gordon, C. J. M. Whitty, et al., “Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa,” The New England Journal of Medicine, vol. 357, no. 24, pp. 2441–2450, 2007. View at Publisher · View at Google Scholar · View at PubMed
33. X. A. Álvarez, C. Sampedro, R. Lozano, and R. Cacabelos, “Citicoline protects hippocampal neurons against apoptosis induced by brain $\beta$-amyloid deposits plus cerebral hypoperfusion in rats,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 21, no. 8, pp. 535–540, 1999. View at Publisher · View at Google Scholar
34. D. Leppert, S. L. Leib, C. Grygar, K. M. Miller, U. B. Schaad, and G. A. Holländer, “Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae,” Clinical Infectious Diseases, vol. 31, no. 1, pp. 80–84, 2000. View at Publisher · View at Google Scholar · View at PubMed
35. S. Starckx, P. E. van den Steen, R. Verbeek, J. M. van Noort, and G. Opdenakker, “A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys $\alpha$B-crystallin and generates a promiscuous T cell epitope,” Journal of Neuroimmunology, vol. 141, no. 1-2, pp. 47–57, 2003. View at Publisher · View at Google Scholar
36. P. Ciborowski, Y. Enose, A. MacK, M. Fladseth, and H. E. Gendelman, “Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease,” Journal of Neuroimmunology, vol. 157, no. 1-2, pp. 11–16, 2004. View at Publisher · View at Google Scholar · View at PubMed
37. N. Khidekel and L. C. Hsieh-Wilson, “A ‘molecular switchboard’—covalent modifications to proteins and their impact on transcription,” Organic and Biomolecular Chemistry, vol. 2, no. 1, pp. 1–7, 2004. View at Publisher · View at Google Scholar · View at PubMed
38. H. B. Armah, N. O. Wilson, B. Y. Sarfo, et al., “Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children,” Malaria Journal, vol. 6, article 147, pp. 1–17, 2007. View at Publisher · View at Google Scholar · View at PubMed
39. A. V. Mudaliar, R. S. Kashyap, H. J. Purohit, G. M. Taori, and H. F. Daginawala, “Detection of 65 kD heat shock protein in cerebrospinal fluid of tuberculous meningitis patients,” BMC Neurology, vol. 6, article 34, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at PubMed
40. V. Lehmensiek, S. D. Süssmuth, J. Brettschneider, et al., “Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS),” Journal of Neuroimmunology, vol. 185, no. 1-2, pp. 190–194, 2007. View at Publisher · View at Google Scholar · View at PubMed
41. K. A. Carlson, P. Ciborowski, C. N. Schellpeper, et al., “Proteomic fingerprinting of HIV-1-infected human monocyte-derived macrophages: a preliminary report,” Journal of Neuroimmunology, vol. 147, no. 1-2, pp. 35–42, 2004. View at Publisher · View at Google Scholar
42. G. Chambers, L. Lawrie, P. Cash, and G. I. Murray, “Proteomics: a new approach to the study of disease,” Journal of Pathology, vol. 192, no. 3, pp. 280–288, 2000. View at Publisher · View at Google Scholar
43. S. Kastenbauer, B. Angele, B. Sporer, H.-W. Pfister, and U. Koedel, “Patterns of protein expression in infectious meningitis: a cerebrospinal fluid protein array analysis,” Journal of Neuroimmunology, vol. 164, no. 1-2, pp. 134–139, 2005. View at Publisher · View at Google Scholar · View at PubMed
44. R. Aebersold and M. Mann, “Mass spectrometry-based proteomics,” Nature, vol. 422, no. 6928, pp. 198–207, 2003. View at Publisher · View at Google Scholar · View at PubMed
45. J. S. Andersen and M. Mann, “Functional genomics by mass spectrometry,” FEBS Letters, vol. 480, no. 1, pp. 25–31, 2000. View at Publisher · View at Google Scholar
46. K. Inada, K. Takahashi, S. Ichinohe, et al., “A silkworm larvae plasma test for detecting peptidoglycan in cerebrospinal fluid is useful for the diagnosis of bacterial meningitis,” Microbiology and Immunology, vol. 47, no. 10, pp. 701–707, 2003.
47. O. Schneider, U. Michel, G. Zysk, O. Dubuis, and R. Nau, “Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations,” Neurology, vol. 53, no. 7, pp. 1584–1587, 1999.
48. P. Balachandran, S. K. Hollingshead, J. C. Paton, and D. E. Briles, “The autolytic enzyme lytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin,” Journal of Bacteriology, vol. 183, no. 10, pp. 3108–3116, 2001. View at Publisher · View at Google Scholar · View at PubMed
49. R. A. Hirst, B. Gosai, A. Rutman, et al., “Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis,” The Journal of Infectious Diseases, vol. 197, no. 5, pp. 744–751, 2008. View at Publisher · View at Google Scholar · View at PubMed
50. B. Ren, A. J. Szalai, S. K. Hollingshead, and D. E. Briles, “Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface,” Infection and Immunity, vol. 72, no. 1, pp. 114–122, 2004. View at Publisher · View at Google Scholar
51. A. Riboldi-Tunnicliffe, N. W. Isaacs, and T. J. Mitchell, “1.2 Å crystal structure of the S. pneumoniae PhtA histidine triad domain a novel zinc binding fold,” FEBS Letters, vol. 579, no. 24, pp. 5353–5360, 2005. View at Publisher · View at Google Scholar · View at PubMed
52. J. E. Adamou, J. H. Heinrichs, A. L. Erwin, et al., “Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis,” Infection and Immunity, vol. 69, no. 2, pp. 949–958, 2001. View at Publisher · View at Google Scholar · View at PubMed
53. S. Dave, S. Carmicle, S. Hammerschmidt, M. K. Pangburn, and L. S. McDaniel, “Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H,” Journal of Immunology, vol. 173, no. 1, pp. 471–477, 2004.
54. A. R. Kerr, G. K. Paterson, J. McCluskey, et al., “The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms,” Infection and Immunity, vol. 74, no. 9, pp. 5319–5324, 2006. View at Publisher · View at Google Scholar · View at PubMed
55. J. C. Paton, P. W. Andrew, G. J. Boulnois, and T. J. Mitchell, “Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins,” Annual Review of Microbiology, vol. 47, pp. 89–115, 1993.
56. H. H. Tong, L. E. Blue, M. A. James, and T. F. DeMaria, “Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model,” Infection and Immunity, vol. 68, no. 2, pp. 921–924, 2000. View at Publisher · View at Google Scholar
57. D. J. Rigden, J. E. Littlejohn, H. V. Joshi, B. L. de Groot, and M. J. Jedrzejas, “Alternate structural conformations of Streptococcus pneumoniae hyaluronan lyase: insights into enzyme flexibility and underlying molecular mechanism of action,” Journal of Molecular Biology, vol. 358, no. 4, pp. 1165–1178, 2006. View at Publisher · View at Google Scholar · View at PubMed
58. M. J. Jedrzejas, “Pneumococcal virulence factors: structure and function,” Microbiology and Molecular Biology Reviews, vol. 65, no. 2, pp. 187–207, 2001. View at Publisher · View at Google Scholar · View at PubMed
59. R. A. Hirst, B. Gosai, A. Rutman, et al., “Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis,” The Journal of Infectious Diseases, vol. 197, no. 5, pp. 744–751, 2008. View at Publisher · View at Google Scholar · View at PubMed
60. C. Sauve, E. Azoulay-Dupuis, P. Moine, et al., “Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae,” Antimicrobial Agents and Chemotherapy, vol. 40, no. 12, pp. 2829–2834, 1996.
61. J. S. Brown, A. D. Ogunniyi, M. C. Woodrow, D. W. Holden, and J. C. Paton, “Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection,” Infection and Immunity, vol. 69, no. 11, pp. 6702–6706, 2001. View at Publisher · View at Google Scholar · View at PubMed
62. E. J. Brown, K. A. Joiner, R. M. Cole, and M. Berger, “Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule,” Infection and Immunity, vol. 39, no. 1, pp. 403–409, 1983.
63. T. van der Poll, C. V. Keogh, X. Guirao, W. A. Buurman, M. Kopf, and S. F. Lowry, “Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia,” The Journal of Infectious Diseases, vol. 176, no. 2, pp. 439–444, 1997.
64. C. A. Dinarello, “The interleukin-1 family: 10 years of discovery,” The FASEB Journal, vol. 8, no. 15, pp. 1314–1325, 1994.
65. P. W. H. I. Parren, P. A. M. Warmerdam, L. C. M. Boeije, et al., “On the interaction of IgG subclasses with the low affinity Fc$\gamma$RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2,” The Journal of Clinical Investigation, vol. 90, no. 4, pp. 1537–1546, 1992. View at Publisher · View at Google Scholar · View at PubMed
66. V. P. Skulachev, “Cytochrome c in the apoptotic and antioxidant cascades,” FEBS Letters, vol. 423, no. 3, pp. 275–280, 1998. View at Publisher · View at Google Scholar
67. R. M. Locksley, N. Killeen, and M. J. Lenardo, “The TNF and TNF receptor superfamilies: integrating mammalian biology,” Cell, vol. 104, no. 4, pp. 487–501, 2001. View at Publisher · View at Google Scholar
68. R. Paul, B. Angele, B. Sporer, H.-W. Pfister, and U. Koedel, “Inflammatory response during bacterial meningitis is unchanged in Fas- and Fas ligand-deficient mice,” Journal of Neuroimmunology, vol. 152, no. 1-2, pp. 78–82, 2004. View at Publisher · View at Google Scholar · View at PubMed
69. R. A. Hirst, B. Gosai, A. Rutman, et al., “Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis,” The Journal of Infectious Diseases, vol. 197, no. 5, pp. 744–751, 2008. View at Publisher · View at Google Scholar · View at PubMed
70. A. M. Berry, R. A. Lock, and J. C. Paton, “Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the Nanb enzyme from recombinant Escherichia coli,” Journal of Bacteriology, vol. 178, no. 16, pp. 4854–4860, 1996.
71. M. Camara, G. J. Boulnois, P. W. Andrew, and T. J. Mitchell, “A neuraminidase from Streptococcus pneumoniae has the features of a surface protein,” Infection and Immunity, vol. 62, no. 9, pp. 3688–3695, 1994.
72. M. Letiembre, H. Echchannaoui, F. Ferracin, S. Rivest, and R. Landmann, “Toll-like receptor-2 deficiency is associated with enhanced brain TNF gene expression during pneumococcal meningitis,” Journal of Neuroimmunology, vol. 168, no. 1-2, pp. 21–33, 2005. View at Publisher · View at Google Scholar · View at PubMed